{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:58:52Z","timestamp":1780595932822,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["UMO-2011\/03\/B\/ST5\/01014"],"award-info":[{"award-number":["UMO-2011\/03\/B\/ST5\/01014"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ejmech.2016.03.061","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T07:47:31Z","timestamp":1458805651000},"page":"216-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Structure\u2013activity relationship studies of new rifamycins containing l -amino acid esters as inhibitors of bacterial RNA polymerases"],"prefix":"10.1016","volume":"116","author":[{"given":"Dominika","family":"Czerwonka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Domagalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystian","family":"Pyta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelina M.","family":"Kubicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Pecyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Gajecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8072-5877","authenticated-orcid":false,"given":"Piotr","family":"Przybylski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.03.061_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/cr030112j","article-title":"Rifamycin e mode of action, resistance, and biosynthesis","volume":"105","author":"Floss","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2016.03.061_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/AAC.01933-12","article-title":"Preliminary pharmacokinetic study of repeated doses of rifampin and rifapentine in guinea pigs","volume":"57","author":"Dutta","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.03.061_bib3","series-title":"Chronicles of Drug Discovery","first-page":"201","article-title":"Rifampicin","author":"Sensi","year":"1982"},{"key":"10.1016\/j.ejmech.2016.03.061_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ijantimicag.2011.01.018","article-title":"Increased rifampicin resistance in blood isolates of meticillin-resistant Staphylococcus aureus (MRSA) amongst patients exposed to rifampicin-containing antituberculous treatment","volume":"37","author":"Tan","year":"2011","journal-title":"Int. J. Antimicrob. Agent"},{"key":"10.1016\/j.ejmech.2016.03.061_bib5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1469-0691.2007.01691.x","article-title":"Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid","volume":"13","author":"Aboltins","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2016.03.061_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/clpt.2011.129","article-title":"Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosis","volume":"90","author":"Ngaimisi","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2016.03.061_bib7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.bmcl.2006.12.026","article-title":"Synthesis and antibacterial evaluation of a novel series of rifabutin-like spirorifamycins","volume":"17","author":"Kim","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.03.061_bib8","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1007\/s00253-015-6682-2","article-title":"Enhanced rifamycin SV production by submerged fermentation using Amycolatopsis mediterranei","volume":"99","author":"Nagavalli","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2016.03.061_bib9","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/jm970791o","article-title":"Comprehensive study on structure-activity relationships of rifamycins: discussion of molecular and crystal structure and spectroscopic and thermochemical properties of rifamycin O","volume":"41","author":"Bacchi","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.03.061_bib10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial RNA polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2016.03.061_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cell.2005.07.014","article-title":"Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins","volume":"122","author":"Artsimovitch","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2016.03.061_bib12","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1021\/jm4004889","article-title":"X-ray crystal structures of the Escherichia coli RNA polymerase in complex with benzoxazinorifamycins","volume":"56","author":"Molodtsov","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.03.061_bib13","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/jm201716n","article-title":"Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases","volume":"55","author":"Gill","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.03.061_bib14","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1039\/c2ob26317c","article-title":"A\u00a0new model of binding of rifampicin and its amino analogues as zwitterions to bacterial RNA polymerase","volume":"10","author":"Pyta","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2016.03.061_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ejmech.2014.07.066","article-title":"Structure and evaluation of antibacterial and antitubercular properties of new basic and heterocyclic 3 formylrifamycin SV derivatives obtained via \u2018click chemistry\u2019 approach","volume":"84","author":"Pyta","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.03.061_bib16","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature752","article-title":"Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 \u00c5 resolution","volume":"417","author":"Vassylyev","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2016.03.061_bib17","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1074\/jbc.M112.430900","article-title":"X-ray crystal structure of Escherichia coli RNA polymerase \u03c370 holoenzyme","volume":"288","author":"Murakami","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.03.061_bib18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.emboj.7600499","article-title":"Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase","volume":"24","author":"Campbell","year":"2005","journal-title":"EMBO"},{"key":"10.1016\/j.ejmech.2016.03.061_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0223-5234(89)90103-7","article-title":"Mechanism of inhibition of DNA-dependent RNA polymerase of Escherichia coli by rifamycins","volume":"24","author":"Cella","year":"1989","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.03.061_bib20","doi-asserted-by":"crossref","first-page":"14820","DOI":"10.1073\/pnas.0802822105","article-title":"Rifamycins do not function by allosteric modulation of binding of Mg2+ to the RNA polymerase active center","volume":"105","author":"Feklistov","year":"2008","journal-title":"Proceed. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2016.03.061_bib21","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1016\/j.bmcl.2015.07.043","article-title":"The effect of complexation of 3-formylrifamycin SV macrocyclic ether derivatives with metal cations and small nitrogen-containing organic molecules on antibacterial activity against S. aureus and S. epidermidis","volume":"25","author":"Przybylski","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.03.061_bib22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.7164\/antibiotics.46.1605","article-title":"Inactivated products of rifampicin by pathogenic Nocardia spp.: structures of glycosylated and phosphorylated metabolites of rifampicin and 3-formylrifamycin SV","volume":"46","author":"Morisaki","year":"1993","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2016.03.061_bib23","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/AAC.39.4.1007","article-title":"Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation","volume":"39","author":"Dabbs","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.03.061_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tet.2014.10.079","article-title":"Rifamycin antibiotics - new compounds and synthetic methods. Part 4: study of the reaction of 3-formylrifamycin SV with secondary amines and ketones","volume":"71","author":"Bujnowski","year":"2015","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2016.03.061_bib25","first-page":"5925","article-title":"Rifamycin antibiotics - new compounds and synthetic methods","volume":"68","author":"Bujnowski","year":"2012"},{"key":"10.1016\/j.ejmech.2016.03.061_bib26","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0040-4020(03)00184-4","article-title":"Rifamycin antibiotics - new compounds and synthetic methods. Part 1: study of the reaction of 3-formylrifamycin SV with primary alkylamines or ammonia","volume":"59","author":"Bujnowski","year":"2003","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2016.03.061_bib27","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1039\/c2ob00008c","article-title":"Intramolecular proton transfer impact on antibacterial properties of ansamycin antibiotic rifampicin and its new amino analogues","volume":"10","author":"Pyta","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2016.03.061_bib28","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1248\/cpb.28.2309","article-title":"Reaction of 3-formylrifamycin SV with formalin in combination with primary alkylamines","volume":"28","author":"Tsukamoto","year":"1980","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2016.03.061_bib29","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/jm00220a009","article-title":"3-N-substituted aminomethyl derivatives of rifamycin SV. A convenient method of synthesis, cyclization of certain derivatives, and anticellular and antiviral activities of several derivatives","volume":"20","author":"McCarthy","year":"1977","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416302446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416302446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T23:25:21Z","timestamp":1536881121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416302446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":29,"alternative-id":["S0223523416302446"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.03.061","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure\u2013activity relationship studies of new rifamycins containing l-amino acid esters as inhibitors of bacterial RNA polymerases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.03.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}